seasonal allergic rhinitis seasonal allergic rhinitis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Men and women between the ages of 18 and 50 years old at the time of informed consent 2) Patients diagnosed with allergic rhinitis 3) Patients with cedar-specific IgE antibodies 4) Patients who have start the treatment of allergic rhinitis 5) Patients who are able to visit Juntendo Hospital or Hongo Otorhinolaryngology Clinic 6) Patients who have given a full explanation of their participation in this study and who have given written consent of their own free will.
Exclusion criteria
Exclusion criteria: 1) Patients undergoing treatment for or with a history of peripheral neuropathy or photosensitivity 2) Patients who are being treated for or have a history of mental illness, stroke, or myocardial infarction 3) Patients who are pregnant or planning to become pregnant during the study period 4) Patients who are using steroids (oral or injectable) or biological agents for the treatment of allergic rhinits 5) Patients who started taking allergic rhinitis medication or who have changed or added to their medication within 4 weeks prior to the start of the intervention. 6) Any other Patients who is deemed by the physician to be ineligible to participate in the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| - Amount of change in allergic rhinitis severity score (sneezing attacks, nasal discharge, nasal obstruction, itchy nose) | — |
Secondary
| Measure | Time frame |
|---|---|
| - Rate of adverse events - Amount of change in QOL score in allergic rhinitis assessed by the Japanese version of Rhinoconjunctivitis Quality of Life Questionnaire (JRQLQ) (No. 1) - Amount of change in sleep quality score evaluated by the Pittsburgh Sleep Questionnaire (Pittsburgh Sleep Questionnaire) | — |
Contacts
Juntendo University Faculty of Medicine